Contact number
+1 215 994 4000About
Provided by Dechert LLP
Excellence across the product life cycle
In today's competitive landscape, innovative leaders in the healthcare and life sciences industries rely on Dechert to navigate their most complex and demanding transactional, intellectual property and litigation matters anywhere in the world.
We represent clients through all stages of the product life cycle – from discovery through development, clinical testing, promotion and sales. We draw on our antitrust, corporate, dispute resolution (litigation and arbitration) intellectual property, product liability, securities, tax and white collar defense, FCPA and corruption investigations lawyers to provide comprehensive solutions to the industry’s most sophisticated challenges.
With dedicated resources deployed at major life sciences hotbeds across the U.S., Europe and Asia, our global team of lawyers collaborates seamlessly to help clients establish or expand their international presence.
Whether guiding a start-up biotech through its first round of commercially significant funding, executing a strategic acquisition for a large pharmaceutical company, licensing a medical device company’s patents or winning antitrust, securities or patent disputes, our lawyers approach every matter with the resources of a major international firm and the focus and depth of a life sciences boutique.
Chambers Review
Dechert has a robust life sciences practice that is propelled by teams in the USA and France. The law firm offers:
• Patent litigation expertise
• Strong capabilities in transactional matters
• Experience in licensing and collaboration agreements
Global leads for the team include Boston-based Andrea Reid, David Rosenthal in New York and Mélanie Thill-Tayara in Paris.
Strengths
Provided by Chambers
"The Dechert team is very experienced and provides excellent service. They couldn't be more responsive and proactive."
"The Dechert team is very experienced and provides excellent service. They couldn't be more responsive and proactive."